Pfizer Inc. (PFE)
26.39
+0.54
(+2.09%)
USD |
NYSE |
May 27, 11:54
Pfizer Cash from Investing (Quarterly) : 785.00M for March 31, 2026
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Johnson & Johnson | -1.04B |
| Eli Lilly & Co. | -3.916B |
| Merck & Co., Inc. | -10.21B |
| Bristol Myers Squibb Co. | -131.00M |
| Arvinas, Inc. | 13.70M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 2.615B |
| Cash from Financing (Quarterly) | -2.856B |
| Free Cash Flow | 9.484B |
| Free Cash Flow Per Share (Quarterly) | 0.3802 |
| Free Cash Flow to Equity (Quarterly) | 5.14B |
| Free Cash Flow to Firm (Quarterly) | 2.750B |
| Free Cash Flow Yield | 6.29% |